NASDAQ:ACER - Acer Therapeutics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$21.73 -0.81 (-3.59 %)
(As of 07/18/2018 06:44 AM ET)
Previous Close$22.55
Today's Range$20.69 - $22.66
52-Week Range$7.35 - $27.80
Volume10,500 shs
Average Volume16,386 shs
Market Capitalization$169.03 million
P/E RatioN/A
Dividend YieldN/A
Beta2.24
Acer Therapeutics logoAcer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. Its product candidates include Celiprolol for the treatment of vascular Ehlers-Danlos syndrome; and ACER-001 for the treatment of urea cycle disorders and maple syrup urine disease. The company was founded in 2013 and is headquartered in Newton, Massachusetts.

Receive ACER News and Ratings via Email

Sign-up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:ACER
CUSIPN/A
Phone844-902-6100

Debt

Debt-to-Equity RatioN/A
Current Ratio5.34
Quick Ratio5.34

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.90 million
Price / Sales56.20
Cash FlowN/A
Price / CashN/A
Book Value$3.03 per share
Price / Book7.17

Profitability

EPS (Most Recent Fiscal Year)($3.84)
Net Income$-14,190,000.00
Net MarginsN/A
Return on Equity-86.30%
Return on Assets-76.75%

Miscellaneous

Employees6
Outstanding Shares7,500,000
Market Cap$169.03

The Truth About Cryptocurrencies

Acer Therapeutics (NASDAQ:ACER) Frequently Asked Questions

What is Acer Therapeutics' stock symbol?

Acer Therapeutics trades on the NASDAQ under the ticker symbol "ACER."

How were Acer Therapeutics' earnings last quarter?

Acer Therapeutics Inc (NASDAQ:ACER) posted its quarterly earnings results on Monday, May, 14th. The biopharmaceutical company reported ($0.53) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.69) by $0.16. View Acer Therapeutics' Earnings History.

What price target have analysts set for ACER?

4 equities research analysts have issued 12-month price targets for Acer Therapeutics' shares. Their forecasts range from $28.00 to $70.00. On average, they anticipate Acer Therapeutics' stock price to reach $49.3333 in the next twelve months. This suggests a possible upside of 127.0% from the stock's current price. View Analyst Ratings for Acer Therapeutics.

What is the consensus analysts' recommendation for Acer Therapeutics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acer Therapeutics in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Acer Therapeutics' key competitors?

Who are Acer Therapeutics' key executives?

Acer Therapeutics' management team includes the folowing people:
  • Mr. Christopher Schelling, Founder, Pres, CEO & Director (Age 42)
  • Mr. Harry S. Palmin, Chief Financial Officer (Age 48)
  • Dr. William T. Andrews M.D., FACP, Chief Medical Officer (Age 53)
  • Mr. Jefferson Davis, Acting Chief Bus. Officer (Age 51)
  • Ms. Kim Tharaldsen, Sr. Director of Marketing

Has Acer Therapeutics been receiving favorable news coverage?

Media coverage about ACER stock has been trending somewhat negative this week, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Acer Therapeutics earned a news sentiment score of -0.02 on Accern's scale. They also gave media headlines about the biopharmaceutical company an impact score of 45.24 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Acer Therapeutics?

Shares of ACER can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Acer Therapeutics' stock price today?

One share of ACER stock can currently be purchased for approximately $21.73.

How big of a company is Acer Therapeutics?

Acer Therapeutics has a market capitalization of $169.03 million and generates $2.90 million in revenue each year. The biopharmaceutical company earns $-14,190,000.00 in net income (profit) each year or ($3.84) on an earnings per share basis. Acer Therapeutics employs 6 workers across the globe.

How can I contact Acer Therapeutics?

Acer Therapeutics' mailing address is 300 WASHINGTON STREET SUITE 351, NEWTON MA, 02458. The biopharmaceutical company can be reached via phone at 844-902-6100 or via email at [email protected]


MarketBeat Community Rating for Acer Therapeutics (NASDAQ ACER)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  121 (Vote Underperform)
Total Votes:  262
MarketBeat's community ratings are surveys of what our community members think about Acer Therapeutics and other stocks. Vote "Outperform" if you believe ACER will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACER will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.